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ABSTRACT
Objective: The aim of this study is to evaluate the in vitro antioxidant activity of Paronychia capitata various extracts, acute toxicity, the in vivo 
antipyretic and anti-inflammatory activities of the n-butanol extract.
Methods: The antioxidant properties were tested using 2,2-diphenyl 1-picrylhydrazyl radical scavenging and β-carotene linoleic acid system, the 
total phenolic and flavonoid contents were determined. Furthermore, anti-inflammatory activity and antipyretic activity of the n-butanol extract 
were assessed on male Wistar rats at the dose levels 250, 500 mg/kg body weight, using the egg albumin-induced edema, and brewer’s yeast-induced 
pyrexia method, respectively.
Results: The n-butanol extract of P. capitata had considerably the highest antiradical activity with inhibitory concentration 50 value of 8.667 µg/ml.
Conclusion: The experimental data demonstrated that n-butanol extract of P. capitata possess significantly remarkable anti-inflammatory and 
antipyretic activities compared to the standard drugs.
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INTRODUCTION
Paronychia is a genus that belongs to the subfamily of 
Paronychioideae [1]. It is represented by five species in the flora of 
Algeria [2]. Paronychia capitata L. known under the name of (Atai el 
Djebel). The infusion of the aerial parts of the plant has been used in 
Spanish folk medicine to purify blood, regulate the circulation and treat 
gout, as well as an agent for dermatitis and as an expectorant [3,4]. 
It is also used as cholagogue, dermatologic, anti-infective, lithotritic, 
diuretic, digestive and antihypertensive [5,6]. Although there are no 
reports of the medicinal uses of P. capitata, the aerial parts of P. argentea 
Lam. are used in the Algerian popular medicine for the treatment of 
renal diseases, diabetes, and as diuretic. This plant is also used to treat 
stomach ulcers, anorexia, bladder and prostate diseases, and heart 
pains [7,8]. According to literature survey, no data are available about 
the therapeutic applications or the biological activity of P. capitata in 
Algeria. Therefore, this study examined the total phenolic and flavonoid 
contents, the antioxidant activity (AA) and the anti-inflammatory and 
antipyretic activities of various extracts of P. capitata collected from the 
East of Algeria.
P. capitata Lam. was collected in May 2015, in Batna, East of Algeria. All 
parts of the plant previously dried and ground into thin powder was 
macerated twice in 70% ethanol for 48 hrs at room temperature. After 
filtration and evaporation of the solvent, the resulting aqueous phase 
undergoes a liquid-liquid extraction with petroleum ether then ethyl 
acetate, and final n-butanol. Evaporation dry organic solutions raised 
the following extracts: The petroleum P. capitata ether extract, ethyl 
acetate extract and the butanol extract. Aqueous extract was prepared 
by boiling the air-dried powdered plant in distilled water for 10 minutes 
and then cooled to room temperature overnight. The aqueous extract 
was filtered using Whatman filter paper. The filtrate was concentrated 
using rotary evaporator and lyophilized.
The total phenolic content of the plant extracts was determined according 
to the Folin-Ciocalteu method [9]. The results were calculated using the 
standard calibration curve of gallic acid (0-200 µg/ml) and expressed 
as micrograms of gallic acid equivalents per milligrams of dry extract 
(µg GAE/mg of extract). Colorimetric aluminum chloride method was 
used for flavonoid determination [10]. Total flavonoid contents were 
calculated from a calibration curve obtained by preparing quercetin 
solutions in methanol (0-40 µg/ml), and expressed in microgram of 
quercetin equivalents per milligrams of dry extract (µg QE/mg of extract).
The free radical scavenging activity of the extracts was measured 
in vitro by 2,2- diphenyl 1-picrylhydrazyl (DPPH) essay [11]. The AA 
of the extracts was expressed as inhibitory concentration (IC50) in 
(µg/ml) and quercetin was used as reference standard. To assess lipid 
peroxidation activity of the samples, β-carotene bleaching essay was 
carried out according to the method described by Kartal et al.[12] After 
the incubation period, the absorbance was measured at 490 nm at 0, 
1, 2, 4, 6, 24, 26, 28, and 48 hrs. All determinations were performed in 
triplicate. The total AA was calculated.
Young male adult Wistar albino rats (150-200 g) were used in these 
experiments. They were housed in plastic cage at temperature of 
(25±2)°C with a 12 light/dark cycle, respectively, before and during 
the experiment, and had free access to drinking water. Animals were 
fed with a standard diet. The oral acute toxicity test was performed 
using ten healthy rats that were allocated in two groups. From 12 hrs 
before to 4 hrs after the oral administration, the animals were fasted 
(animals had water but not food) and weighed. The essay was followed 
as Organization for Economic Co-operation and Development Guideline 
425 [13]. The control group received normal saline 10 ml/kg body 
weight by gavage, whereas the exposed groups (Groups 1) received 
2000 mg/kg n-butanol extracts of P. capitata. Animals were observed 
during the first 30 minutes, 2, 4, and 6 hrs after treatment, and daily 
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thereafter for a total of 14 days in terms of weight loss, mortality, 
changes in behavior, skin, eyes, and fur.
The anti-inflammatory effect was assessed in acute inflammation 
method already described by Anosike et al. [14] Initially, normal 
paw thickness of each rat was noted. Inflammation was produced by 
injection of 0.1 ml of undiluted fresh egg albumin into the sub planter 
surface of the right hand paw of each rat 1 hr after oral administration 
of P. capitata butanol extract (PCBU 250, 500 mg/kg body weight), 
or diclofenac (Phamalliance, Ouled-Fayet, Algiers- Algeria) (DICLO; 
30 mg/kg body weight). The control group was received 10 ml/kg of 
normal saline. The paw thickness was measured before injecting egg 
albumin and after 30, 60, 120, 180, 240, and 300 minutes using Vernier 
caliper (Shanghai Shenhan China).
Before the start of the antipyretic activity experiment, the animals were 
divided into four groups, each of five rats. The rectal temperature of each 
one was recorded using digital thermometer (VEDO Lente- Artsana, 
Italy) and then pyrexia was induced by subcutaneous injection of 
20 % w/v of brewer’s yeast (10 ml/kg) in normal saline [15]. All 
groups were fasted overnight, after 18 hrs rectal temperature of 
each rat was recorded. Group I received normal saline (10 ml/kg) as 
a negative control, Group II received paracetamol (Winthrop Pharma 
Saidal. Oued-Smar. Algeria) (PARA 150 mg/kg) as a standard drug [16] 
while the remaining Groups III and IV received 250, 500 mg/kg PCBU, 
respectively. After drug administration, the rectal temperature was 
then recorded over 5 hrs.
The data of the in vivo activities were analyzed using one-way analysis 
variance (ANOVA) followed by Dunnett’s test for individual comparison 
of groups with control. All values were expressed as mean±standard 
error of the mean (n=5). Values were considered statistically significant 
when p<0.01. The in vitro data were reported as mean ± standard 
deviation of three replicates (n=3). The data were analyzed using one-
way ANOVA and Newman-Keuls post-test.
The amount of total phenolics varied in different extracts and ranged 
from 05.140 to 32.238 µg GAE/mg of dry extract. The results indicated 
that PCBU (32.238±1.404 µg GAE/mg) has the highest phenolic content, 
and the P. capitata ethyl acetate extract (05.140±0.132 µg GAE/mg) has 
the lowest phenolic contents. However, the highest flavonoid contents 
(6.077±0.443 µg QE/mg of dry extract) was found in P. capitata aqueous 
extract among the various extracts of P. capitata as shown in Table 1.
The extracts of P. capitata were screened for their possible AA by two 
complementary test systems; the DPPH free radical scavenging and 
the β-carotene/linoleic acid system. For the DPPH radical scavenging 
activity, all the sample extracts exhibited significant dose-dependent 
activity. Moreover, the results indicated in Table 1 show that the 
butanol fraction PCBU has the lowest IC50 (8.667±0.577 µg/ml) among 
extracts of P. capitata which is comparable to the one of standard 
quercetins. On the other hand, the comparable β-carotene bleaching 
rates of the positive control butylated hydroxytoluene (BHT) and 
P. capitata different extracts (Table 1). The butanol fraction PCBU 
shows the maximum inhibition (84.92%) which is close to the positive 
control BHT.
Acute oral toxicity; during the 14 days treatment, no significant 
difference (p>0.01) was recorded between the experimental and 
control group. The safety of the extract is evidenced by the high LD50 
Table 2: Anti-inflammatory effect of diclofenac and the n-butanol extract of P. capitata against egg albumin-induced paw oedema in rats
PAW THICKNESS±SEM (mm)
TREATMENT DOSE (mg/kg) 30 minutes 1 hr 2 hrs 3 hrs 4 hrs 5 hrs
Control 10 ml/kg 9.340±0.145 7.678±0.134 6.534±0.151 6.196±0.109 4.936±0.158 4.070±0.077
DICLO 30 6.418±0.157*** 5.340±0.121*** 4.492±0.193*** 3.402±0.097*** 3.120±0.138*** 2.710±0.187***
PCBU 500 7.314±0.185*** 6.074±0.106*** 4.714±0.237*** 3.958±0.181*** 2.996±0.214*** 3.358±0.197**
PCBU 250 7.604±0.036*** 6.198±0.066*** 4.712±0.210*** 3.904±0.095*** 3.352±0.182*** 3.366±0.228*
All values were expressed as mean±SEM (n=5). *Significantly different from the control at the corresponding time P<0.01, P. capitata: Paronychia capitata,  SEM: Standard 
error of the mean, PCBU: P. capitata butanol extract, ** moderately significant compared with the control P<0.01, *** highly significant compared with the control P<0.001.
Table 3: Antipyretic activity of n-butanol extract of P. capitata and paracetamol on yeast induced pyrexia in rats
RECTAL TEMPERATURE (°C) BEFORE AND AFTER TREATMENT
TREATMENT 0 hr 18 hrs 18 hrs 
30 minutes
19 hrs 20 hrs 21 hrs 22 hrs 23 hrs
Control 36.70±0.341 38.10±0.161 38.10±0.161 38.10±0.161 38.00±0.162 38.00±0.171 38.00±0.171 37.90±0.172
Paracetamol 36.54±0.258 37.88±0.222 37.74±0.224 ns 37.50±0.164 *** 37.20±0.176*** 36.92±0.196*** 36.76±0.206*** 36.60±0.230***
PCBU500 mg/kg 36.26±0.304 37.95±0.189 37.84±0.112 ns 37.60±0.148** 37.20±0.189*** 37.00±0.216*** 36.68±0.228*** 36.44±0.290***
PCBU250 mg/kg 36.24±0.299 37.60±0.158 37.64±0.156 ns 37.44±0.160 ns 37.18±0.168* 37.02±0.180** 36.82±0.228** 36.70±0.225**
All values were expressed as mean±SEM (n=5). *Significantly different from the control at the corresponding time P<0.01, SEM: Standard error of the mean, P. capitata: 
Paronychia capitata, PCBU: P. capitata butanol extract, ** moderately significant compared with the control P<0.01, *** highly significant compared with the control P<0.001.
Table 1: Total phenolic and flavonoid contents, effects of P. capitata L. various extracts and positive control (quercetin, BHT) on the 
in vitro free radical (DPPH) scavenging and in β-carotene/linoleic acid system
EXTRACTS TOTAL PHENOLICa TOTAL FLAVONOIDb IC50 (µg/ml) ANTIOXIDANT ACTIVITY (%)
PCBU 32.238±1.404a 3.481±0.185a 08.667±0.577a 84.916±2.401a
PCAC 05.140±0.132c 2.648±0.754a 11.333±0.577b 74.082±1.470b
PCEP 29.062±0.884c 3.113±0.581a 24.046±1.000c 66.540±5.182b
PCAQ 10.199±2.24b 6.077±0.443b 16.000±0.000d 42.852±2.779c
QUERCETIN / / 1.149±0.0004 /
BHT / / / 99.167±1.056
Mean±SD (n=3). aExpressed as microgram of gallic acid per milligram dry extract, bExpressed as microgram of quercetin per milligram dry extract. Means in the same 
column sharing different letters are significantly different P<0.05, BHT: Butylated hydroxytoluene, DPPH: 2,2-diphenyl 1-picrylhydrazyl, SD: Standard deviation, 
IC50: Inhibitory concentration, P. capitata: Paronychia capitata, PCEP: P. capitata ether extract, PCAC: P. capitata ethyl acetate extract, PCAQ: P. capitata aqueous extract
179
Asian J Pharm Clin Res, Vol 10, Issue 3, 2017, 177-179
 Soumia et al. 
value of the butanol extract (>2000 mg/kg). The investigation of the 
anti-inflammatory activity of n-butanol extract of P. capitata L. was 
assessed using egg albumin induced paw edema method. The study 
showed that the extract had a significant effect on inflammation 
and reduced clearly the swelling. As shown in Table 2, the n-butanol 
fraction evoked a non-dose related anti-inflammatory activity and 
inhibited significantly the increase of paw edema from 30 minutes to 
5 hrs. The maximum inhibitory effect (96.63%) was recorded at the 
dose 500 mg/kg of the n-butanol extract after 5 hrs. The effect of the 
n-butanol fraction on yeast-induced pyrexia is presented in Table 3. 
Treatment with n-butanol extract of P. capitata revealed a significant 
decrease (p<0.01) in rectal temperature between 2 and 5 hrs after 
administration, in a dose-dependent manner when compared to the 
control The antipyretic effect was observed from the first hour at the 
dose of 500 mg/kg and paracetamol (150 mg/kg), which was further 
maintained for 5 hrs. However, at the 250 mg/kg dose of n-butanol 
extract of P. capitata showed a moderate antipyretic activity after 2 hrs.
The results of this study proved the antioxidant anti-inflammatory 
and antipyretic activities of P. capitata extracts. Moreover, this study 
indicates that this plant may be useful in the protection against 
inflammatory diseases. However, phytochemical study is necessary to 
identify the active principles and exact mechanisms of action.
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